oncology in AL

Discussion in 'Daiichi-Sankyo' started by anonymous, Apr 17, 2018 at 11:50 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Do you really need to ask????
     

  2. anonymous

    anonymous Guest

    launching three oncology products (true oncology products) over the next 12 months. For all the folks that are going to reply....you don't have any oncology products google clinical trials dot gov and search ds
     
  3. anonymous

    anonymous Guest

    Both trials were done months ago and still no submission, pex is not Oncology and quiz is way too late and complicated to have success. Sorry but a listing of a failed and delayed trial means nothing and you clearly know nothing about oncology like everyone here
     
  4. anonymous

    anonymous Guest

    You have two failed drugs, they completed a year ago and not submitted what does that tell you dummie? Three? You can’t count either I guess
     
  5. anonymous

    anonymous Guest

    Three oncology meds in next year?? No way! Only launch that may be coming in next year is Welchol candy bar. Even that is delayed or not coming.
     
  6. anonymous

    anonymous Guest

    really what are they? One finished over a year ago blew up livers and still not filed, crickets, one is the third to market and had a terrible dose and also done but not filed and any others are years away and based on our history never see the light of day but go ahead pal, stay ignorant
     
  7. anonymous

    anonymous Guest

    So .... being honest and up front what are your thoughts as to what is going to happen ? Just concerned wanting insight
     
  8. anonymous

    anonymous Guest

    Don’t quit another job
     
  9. anonymous

    anonymous Guest

    They will both launch. I don't know how long they will last. If you can get promoted from DSI it's definitely a step up (even though they won't pay). Then you can market yourself as a "true" oncology rep, add your time with the company, and show career progression. I would definitely start looking after 6 months however.

    Anybody coming from outside, make sure you get the base you are looking for, however, I don't think they are going to pay.

    Some former Amgen people told me that Ken is not happy. My guess (and I stress guess) is that he will leave when he gets the oncology drugs launched.
     
  10. anonymous

    anonymous Guest

    Pex has not been filed, wouldn’t be approved and isn’t even an oncolgy drug. Quiz has had tons of delay the study is complete but no results when is the last time a company had a positive study that they sat on? Remover Miro kept pushing back updates? Until they said guess what it failed this is the same dam thing
     
  11. anonymous

    anonymous Guest

    clinicaltrials.gov lists the Q study completion date as July 2019. There are strict guidelines on what can be published and when. So the study is not complete. Facts, please, facts!!
     
  12. anonymous

    anonymous Guest

    Study completion dates are estimates, it depends on many sites sign up, how many patients are recruited, is it an event driven trial. Is there a mandated extension. Take some time to learn drug design.the study once done has to have the data compiled and submitted to the FDA for their review. Best case is 15 months from today and it’s one of three in the same class and we know how that goes here. But hey we got RB! Oh wait no we don’t
     
  13. anonymous

    anonymous Guest

    AML franchise...LOL

     
  14. anonymous

    anonymous Guest

    absolute joke guys wise up
     
  15. anonymous

    anonymous Guest

    lol
     
  16. anonymous

    anonymous Guest

    what are they saying about the astellas product? looks better?
     
  17. anonymous

    anonymous Guest


    Teeny tiny market but both drugs will have a place in the treatment algorithm
     
  18. anonymous

    anonymous Guest

    better data, will have more indications and dirstbti market, sound familiar? They will beat us bad and our dosing is pretty rough
     
  19. anonymous

    anonymous Guest

    ONC leadership is a joke, none of the three have ever worked in an Onc product let alone launched ! Keith will tell you injectaferwhich only supports he doesn’t have a clue and this is our plan for success?
     
  20. anonymous

    anonymous Guest

    wanna have a good time?? Ask TW, KF or KW to tell you about their oncology launch experience. It will take a minute seeing as they ain’t never done it